Brenton K. Ahrens
Chairman
Iterum Therapeutics plc (ITRMF)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brenton K. Ahrens
Brenton K. Ahrens is recorded as Chairman at Iterum Therapeutics plc (ITRMF).
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2022-04-25
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Iterum Therapeutics plc
Other people whose current roles at this company are on record from its filings.
- David Kelly Chairman
- Beth Hecht Board Member
- Beth P. Hecht Board Member
- Corey Fishman Board Member
- David G. Kelly Board Member
- Joseph J. Whalen Board Member
- Michael Dunne, M.D. Board Member
- Michael W. Dunne Board Member
Recent activity
No call appearances or filed executive changes recorded yet.